Boston Trust Walden Corp raised its stake in Oracle Corporation (NYSE:ORCL - Free Report) by 4.3% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 588,142 shares of the enterprise software provider's stock after buying an additional 24,112 shares during the quarter. Boston Trust Walden Corp's holdings in Oracle were worth $82,228,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Sunbeam Capital Management LLC bought a new position in Oracle during the fourth quarter valued at about $30,000. Hurley Capital LLC bought a new position in shares of Oracle in the fourth quarter valued at $33,000. Synergy Investment Management LLC bought a new stake in shares of Oracle during the 4th quarter worth $34,000. Mpwm Advisory Solutions LLC acquired a new position in shares of Oracle in the 4th quarter worth $36,000. Finally, Fourth Dimension Wealth LLC acquired a new stake in shares of Oracle during the fourth quarter worth $36,000. Institutional investors and hedge funds own 42.44% of the company's stock.
Analysts Set New Price Targets
ORCL has been the subject of a number of recent analyst reports. DA Davidson increased their price target on Oracle from $140.00 to $170.00 and gave the company a "neutral" rating in a research report on Thursday, June 12th. BMO Capital Markets upgraded shares of Oracle from a "market perform" rating to an "outperform" rating and raised their target price for the stock from $200.00 to $235.00 in a report on Friday, June 13th. Evercore ISI restated a "buy" rating on shares of Oracle in a report on Wednesday. Oppenheimer reaffirmed an "outperform" rating on shares of Oracle in a research note on Wednesday. Finally, Loop Capital set a $135.00 target price on shares of Oracle in a research note on Tuesday, June 10th. Eleven investment analysts have rated the stock with a hold rating, twenty-one have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $196.74.
Read Our Latest Report on ORCL
Oracle Stock Performance
Shares of ORCL traded up $2.45 on Thursday, reaching $210.63. 15,046,293 shares of the company's stock traded hands, compared to its average volume of 9,813,175. The stock has a market cap of $589.13 billion, a PE ratio of 48.53, a PEG ratio of 3.12 and a beta of 1.32. The company has a current ratio of 0.75, a quick ratio of 1.02 and a debt-to-equity ratio of 4.07. The stock's 50 day simple moving average is $157.39 and its two-hundred day simple moving average is $161.16. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $216.60.
Oracle (NYSE:ORCL - Get Free Report) last released its earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 EPS for the quarter, topping analysts' consensus estimates of $1.64 by $0.06. The company had revenue of $15.90 billion for the quarter, compared to analysts' expectations of $15.58 billion. Oracle had a return on equity of 87.34% and a net margin of 21.68%. The business's revenue for the quarter was up 11.3% compared to the same quarter last year. During the same period in the previous year, the business posted $1.63 EPS. On average, analysts forecast that Oracle Corporation will post 5 earnings per share for the current fiscal year.
Oracle Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 24th. Investors of record on Thursday, July 10th will be paid a dividend of $0.50 per share. The ex-dividend date is Thursday, July 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.95%. Oracle's payout ratio is 46.08%.
Insider Buying and Selling
In other Oracle news, Vice Chairman Jeffrey Henley sold 400,000 shares of the company's stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $190.42, for a total value of $76,168,000.00. Following the transaction, the insider now directly owns 1,097,576 shares in the company, valued at $209,000,421.92. This represents a 26.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Naomi O. Seligman sold 2,000 shares of Oracle stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $145.81, for a total value of $291,620.00. Following the sale, the director now owns 34,630 shares of the company's stock, valued at approximately $5,049,400.30. This trade represents a 5.46% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 427,366 shares of company stock valued at $80,183,723. Corporate insiders own 42.20% of the company's stock.
About Oracle
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Recommended Stories

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.